Establishment and characterization of a tumorigenic cell line from areca quid and tobacco smoke-associated buccal carcinoma

Oral Oncology

Volumn 43, Issue 7, 2007, Pages 639-647

  Kok, Sang Heng ^a,b   Hong, Chi Yuan ^a,b,c   Lin, Sze Kwan ^a,b   Lee, Jang Jaer ^a,b   Chiang, Chun Pin ^a,b   Kuo, Mark Yen Ping ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Areca quid; Cell line; Oral squamous cell carcinoma; p53; Taiwan; Tobacco smoke; Tumorigenicity

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYSTEINE; FAS ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P16INK4A; PROTEIN P53; TYROSINE;

ARTICLE; BETEL NUT; CELL LINE; CELL STRUCTURE; CHROMOSOME; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; TUMOR CELL;

ARECA; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHEEK; DNA MUTATIONAL ANALYSIS; GENES, P53; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; SMOKING;

EID: 34447305732     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.07.007     Document Type: Article

References (64)

1. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80 6 (1999) 827-841
2. La Vecchia C., Tavani A., Franceschi S., Levi F., Corrao G., and Negri E. Epidemiology and prevention of oral cancer. Oral Oncol 33 5 (1997) 302-312
3. Takezaki T., Hirose K., Inoue M., Hamajima N., Kuroishi T., Nakamura S., et al. Tobacco, alcohol and dietary factors associated with the risk of oral cancer among Japanese. Jpn J Cancer Res 87 6 (1996) 555-562
4. Hecht S.S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3 10 (2003) 733-744
5. Seitz H.K., Matsuzaki S., Yokoyama A., Homann N., Vakevainen S., and Wang X.D. Alcohol and cancer. Alcohol Clin Exp Res 25 5 Suppl ISBRA (2001) 137S-143S
6. Notani P.N. Epidemiology and prevention of head and neck cancer: a global view. In: Saranath D. (Ed). Contemporary issues in oral cancer (2000), Oxford University Press, New Delhi 1-29
7. Ko Y.C., Chiang T.A., Chang S.J., and Hsieh S.F. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med 21 6 (1992) 261-264
8. Sundqvist K., Liu Y., Nair J., Bartsch H., Arvidson K., and Grafstrom R.C. Cytotoxic and genotoxic effects of areca nut-related compounds in cultured human buccal epithelial cells. Cancer Res 49 19 (1989) 5294-5298
9. Dave B.J., Trivedi A.H., and Adhvaryu S.G. Role of areca nut consumption in the cause of oral cancers: a cytogenetic assessment. Cancer 70 5 (1992) 1017-1023
10. Diaz Jr. E.M., Holsinger F.C., Zuniga E.R., Roberts D.B., and Sorensen D.M. Squamous cell carcinoma of the buccal mucosa: one institution's experience with 119 previously untreated patients. Head Neck 25 4 (2003) 267-273
11. Malaovalla A.M., Silverman S., Mani N.J., Bilimoria K.F., and Smith L.W. Oral cancer in 57,518 industrial workers of Gujarat, India: a prevalence and followup study. Cancer 37 4 (1976) 1882-1886
12. Chen Y.K., Huang H.C., Lin L.M., and Lin C.C. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol 35 2 (1999) 173-179
13. Schwartz J.L., Gu X., Kittles R.A., Baptiste A., and Shklar G. Experimental oral carcinoma of the tongue and buccal mucosa: possible biologic markers linked to cancers at two anatomic sites. Oral Oncol 36 2 (2000) 225-235
14. Paterson I.C., Eveson J.W., and Prime S.S. Molecular changes in oral cancer may reflect aetiology and ethnic origin. Eur J Cancer B Oral Oncol 32 3 (1996) 150-153
15. Scully C., Field J.K., and Tanezawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 36 3 (2000) 256-263
16. Ko Y.C., Huang Y.L., Lee C.H., Chen M.J., Lin L.M., and Tsai C.C. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 24 10 (1995) 450-453
17. Lee C.H., Ko Y.C., Huang H.L., Chao Y.Y., Tsai C.C., Shieh T.Y., et al. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer 88 3 (2003) 366-372
18. Wen C.P., Tsai S.P., Cheng T.Y., Chen C.J., Levy D.T., Yang H.J., et al. Uncovering the relation between betel quid chewing and cigarette smoking in Taiwan. Tob Control 14 Suppl. 1 (2005) i16-i22
19. Lin S.C., Liu C.J., Chiu C.P., Chang S.M., Lu S.Y., and Chen Y.J. Establishment of OC3 oral carcinoma cell line and identification of NF-kappa B activation responses to areca nut extract. J Oral Pathol Med 33 2 (2004) 79-86
20. Wong D.Y., Chang K.W., Chen C.F., and Chang R.C. Characterization of two new cell lines derived from oral cavity human squamous cell carcinomas-OC1 and OC2. J Oral Maxillofac Surg 48 4 (1990) 385-390
21. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56 11 (1996) 2488-2492
22. Hedberg J.J., Grafstrom R.C., Vondracek M., Sarang Z., Warngard L., and Hoog J.O. Micro-array chip analysis of carbonylmetabolising enzymes in normal, immortalised and malignant human oral keratinocytes. Cell Mol Life Sci 58 11 (2001) 1719-1726
23. Alevizos I., Mahadevappa M., Zhang X., Ohyama H., Kohno Y., Posner M., et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 20 43 (2001) 6196-6204
24. Jia L.Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., et al. Screening the p53 status of human cell lines using a yeast functional assay. Mol Carcinog 19 4 (1997) 243-253
25. Kok S.H., Cheng S.J., Hong C.Y., Lee J.J., Lin S.K., Kuo Y.S., et al. Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio. Cancer Lett 217 1 (2005) 43-52
26. Kok SH. Pathogenesis and treatment of oral squamous cell carcinomas. PhD thesis. National Taiwan University, Taipei, Taiwan; 2003.
27. Ota I., Ohnishi K., Takahashi A., Yane K., Kanata H., Miyahara H., et al. Transfection with mutant p53 gene inhibits heat-induced apoptosis in a head and neck cell line of human squamous cell carcinoma. Int J Radiat Oncol Biol Phys 47 2 (2000) 495-501
28. Nakahara Y., Shintani S., Mihara M., Ueyama Y., and Matsumura T. High frequency of homozygous deletion and methylation of p16(INK4A) gene in oral squamous cell carcinomas. Cancer Lett 163 2 (2001) 221-228
29. Viswanathan M., Tsuchida N., and Shanmugam G. Selective deletion of p14(ARF) exon 1beta of the INK4a locus in oral squamous cell carcinomas of Indians. Oral Oncol 37 4 (2001) 341-344
30. Viswanathan M., Tsuchida N., and Shanmugam G. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer 105 1 (2003) 41-46
31. Kresty L.A., Mallery S.R., Knobloch T.J., Song H., Lloyd M., Casto B.C., et al. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res 62 18 (2002) 5295-5300
32. Lin S.C., Chang K.W., Chang C.S., Liu T.Y., Tzeng Y.S., Yang F.S., et al. Alterations of p16/MTS1 gene in oral squamous cell carcinomas from Taiwanese. J Oral Pathol Med 29 4 (2000) 159-166
33. Kudo Y., Takata T., Yasui W., Ogawa I., Miyauchi M., Takekoshi T., et al. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is an indicator of malignant behavior in oral squamous cell carcinoma. Cancer 83 12 (1998) 2447-2455
34. Mineta H., Miura K., Suzuki I., Takebayashi S., Amano H., Araki K., et al. Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. Cancer 85 5 (1999) 1011-1017
35. Slingerland J.M., and Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 183 1 (2000) 10-17
36. Kuo M.Y., Hsu H.Y., Kok S.H., Kuo R.C., Yang H., Hahn L.J., et al. Prognostic role of p27(Kip1) expression in oral squamous cell carcinoma in Taiwan. Oral Oncol 38 2 (2002) 172-178
37. Erber R., Klein W., Andl T., Enders C., Born A.I., Conradt C., et al. Aberrant p21(CIP1/WAF1) protein accumulation in head-and-neck cancer. Int J Cancer 74 4 (1997) 383-389
38. van Oijen M.G., Tilanus M.G., Medema R.H., and Slootweg P.J. Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med 27 8 (1998) 367-375
39. Yook J.I., and Kim J. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. Oral Oncol 34 3 (1998) 198-203
40. Weinberg W.C., and Denning M.F. P21Waf1 control of epithelial cell cycle and cell fate. Crit Rev Oral Biol Med 13 6 (2002) 453-464
41. Kuo Y.M., Huang J.S., Kok S.H., Kuo Y.S., and Chiang C.P. Prognostic role of p21WAF1 expression in areca quid chewing and smoking-associated oral squamous cell carcinoma in Taiwan. J Oral Pathol Med 31 1 (2002) 16-22
42. Korsmeyer S.J. Regulators of cell death. Trends Genet 11 3 (1995) 101-105
43. Jordan R.C.K., Catzavelos G.C., Barrett A.W., and Speight P.M. Differential expression of Bcl-2 and Bax in squamous cell carcinomas of the oral cavity. Eur J Cancer B Oral Oncol 32 6 (1996) 394-400
44. Ravi D., Ramadas K., Mathew B.S., Nalinakumari K.R., Nair M.K., and Pillai M.R. De novo programmed cell death in oral cancer. Histopathology 34 3 (1999) 241-249
45. Yao L., Iwai M., and Furuta I. Correlations of Bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas. Oral Oncol 35 1 (1999) 56-62
46. Sulkowska M., Famulski W., Chyczewski L., and Sulkowski S. Evaluation of p53 and Bcl-2 oncoprotein expression in precancerous lesions of the oral cavity. Neoplasma 48 2 (2001) 94-98
47. Schoelch M.L., Le Q.T., Silverman Jr. S., McMillan A., Dekker N.P., Fu K.K., et al. Apoptosis-associated proteins and the development of oral squamous cell carcinoma. Oral Oncol 35 1 (1999) 77-85
48. McAlinden R.L., Maxwell P., Napier S., Hamilton P., Cowan C.G., Lundy F.T., et al. Bcl-2 expression in sequential biopsies of potentially malignant oral mucosal lesions assessed by immunocytochemistry. Oral Dis 6 5 (2000) 318-326
49. Schwartz J.L., Gu X., Kittles R.A., Baptiste A., and Shklar G. Experimental oral carcinoma of the tongue and buccal mucosa: possible biologic markers linked to cancers at two anatomical sites. Oral Oncol 36 2 (2000) 225-235
50. Loro L.L., Vintermyr O.K., Liavaag P.G., Jonsson R., and Johannessen A.C. Oral squamous cell carcinoma is associated with decreased Bcl-2/Bax expression ratio and increased apoptosis. Human Pathol 30 9 (1999) 1097-1105
51. Chen Y., Kayano T., and Takagi M. Dysregulated expression of Bcl-2 and Bax in oral carcinomas: evidence of post-transcriptional control. J Oral Pathol Med 29 2 (2000) 63-69
52. Xie X., Clausen O.P.F., De Angelis P., and Boysen M. The prognostic value of spontaneous apoptosis, Bax, Bcl-2 and p53 in oral squamous cell carcinoma of the tongue. Cancer 86 6 (1999) 913-920
53. Ito T., Fujieda S., Tsuzuki H., Sunaga H., Fan G., Sugimoto C., et al. Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma. Cancer Lett 140 1-2 (1999) 81-91
54. Loro L.L., Vintermyr O.K., Liavaag P.G., Johannessen A.C., and Jonsson R. Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma. J Oral Pathol Med 28 2 (1999) 82-87
55. Chen Q., Samaranayake L.P., Zhen X., Luo G., Nie M., and Li B. Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis. Oral Oncol 35 6 (1999) 548-553
56. Sundelin K., Jadner M., Norberg-Spaak L., Davidsson A., and Hellquist H.B. Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue. Eur J Cancer 33 11 (1997) 1860-1864
57. Muraki Y., Yoshioka C., Tateishi A., Fukuda J., Haneji T., and Kobayashi N. Localization of Fas antigen in oral squamous cell carcinoma. Br J Oral Maxillofac Surg 37 1 (1999) 37-40
58. Jackel M.C., Mitteldorf C., Schweyer S., and Fuzesi L. Clinical relevance of Fas (APO-1/CD95) expression in laryngeal squamous cell carcinoma. Head Neck 23 8 (2001) 646-652
59. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 6810 (2001) 307-310
60. Cho Y., Gorina S., Jeffrey P.D., and Pavletich N.P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265 5170 (1994) 346-355
61. Bullock A.N., and Fersht A.R. Rescuing the function of mutant p53. Nat Rev Cancer 1 1 (2001) 68-76
62. Reddy S., Piccione D., Takita H., and Bankert R.B. Human lung tumor growth established in the lung and subcutaneous tissue of mice with severe combined immunodeficiency. Cancer Res 47 9 (1987) 2456-2460
63. Mueller B.M., and Reisfeld R.A. Potential of the SCID mouse as a host for human tumors. Cancer Metastasis Rev 10 3 (1991) 193-200
64. Bankert R.B., Egilmez N.K., and Hess S.D. Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies. Trends Immunol 22 7 (2001) 386-393